| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/21/2002 | WO2001039803A3 Interleukin-1 muteins useful as vaccine adjuvants |
| 02/21/2002 | WO2001031005A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/21/2002 | WO2001030300A3 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 02/21/2002 | US20020022717 Using monoclonal antibodies |
| 02/21/2002 | US20020022591 Polynucleotides and polypeptides comprising an ovarian tumor protein, antibodies directed against said polypeptides; diagnostic kits |
| 02/21/2002 | US20020022248 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 02/21/2002 | US20020022035 Genetic engineering; deactivating toxin |
| 02/21/2002 | US20020022034 Therapeutic DNA vaccination |
| 02/21/2002 | US20020022033 Diagnosis of Aids |
| 02/21/2002 | US20020022031 Immunotherapy for chronic myelocytic leukemia |
| 02/21/2002 | US20020022030 Product and process for regulation of T cell responses |
| 02/21/2002 | US20020022029 Human RRP sequences and methods of use |
| 02/21/2002 | US20020022028 Integrin antagonist; bone disorders |
| 02/21/2002 | US20020022020 Induction lymphocyte tolerance |
| 02/21/2002 | US20020022017 Antitumor agents; fusion protein containing colony stimulanting factor |
| 02/21/2002 | CA2431954A1 A retroviral immunotherapy |
| 02/21/2002 | CA2424160A1 Oral solid dose vaccine |
| 02/21/2002 | CA2420037A1 Immunogenic hbc chimer particles having enhanced stability |
| 02/21/2002 | CA2419790A1 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 02/21/2002 | CA2419533A1 Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies |
| 02/21/2002 | CA2419425A1 Novel diagnostic agents of chronic or persistent chlamydial diseases and uses thereof |
| 02/21/2002 | CA2419418A1 Vaccines containing ribavirin and methods of use thereof |
| 02/21/2002 | CA2419245A1 Adeno-associated virus-mediated delivery of angiogenic factors |
| 02/21/2002 | CA2419182A1 Malaria immunogen and vaccine |
| 02/21/2002 | CA2419133A1 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth |
| 02/21/2002 | CA2419020A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
| 02/21/2002 | CA2418854A1 A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof |
| 02/21/2002 | CA2418725A1 Claudin polypeptides |
| 02/21/2002 | CA2418303A1 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 02/21/2002 | CA2418266A1 Novel mitogen activated kinase |
| 02/21/2002 | CA2417152A1 Therapeutic compounds for ovarian cancer |
| 02/21/2002 | CA2417141A1 Novel glycoproteins and methods of use thereof |
| 02/21/2002 | CA2416898A1 Method and composition for altering a b cell mediated pathology |
| 02/21/2002 | CA2416794A1 Method and composition for altering a t cell mediated pathology |
| 02/21/2002 | CA2415353A1 Use of antibodies against specific mhc-peptide complexes |
| 02/20/2002 | EP1180525A1 Transcriptional activation inhibitory protein |
| 02/20/2002 | EP1180369A1 MEDICINAL COMPOSITIONS CONTAINING ANTI-Fas ANTIBODY |
| 02/20/2002 | EP1180168A1 MOLECULAR CHARACTERISATION OF CHROMOSOME TRANSLOCATION t(11;18)(q21;q21) AND ITS CORRELATION TO CARCINOGENESIS |
| 02/20/2002 | EP1180155A1 Vector for integration of heterologous sequences into poxviral genomes |
| 02/20/2002 | EP1180150A2 Nucleic acid immunization |
| 02/20/2002 | EP1180146A1 Secreted alpha-helical protein - 32 |
| 02/20/2002 | EP1180145A1 Biosynthesis of foreign proteins using transformed microalgae |
| 02/20/2002 | EP1180144A2 Cytoskeleton-associated proteins |
| 02/20/2002 | EP1180123A1 Immunoconjugates having high binding affinity |
| 02/20/2002 | EP1180120A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
| 02/20/2002 | EP1180119A2 RECOMBINANT $i(HAEMOPHILUS INFLUENZAE) ADHESIN PROTEINS |
| 02/20/2002 | EP1180118A1 Fimbrial proteins |
| 02/20/2002 | EP1180109A1 Prodrug activation using catalytic antibodies |
| 02/20/2002 | EP1180042A1 Model membrane systems |
| 02/20/2002 | EP1180040A2 Methods for treating congestive heart failure |
| 02/20/2002 | EP1180031A1 Noscapine derivatives as adjuvant compositions and methods of use thereof |
| 02/20/2002 | EP0874992B1 Compounds and methods for the detection and prevention of t. cruzi infection |
| 02/20/2002 | EP0728215B1 METHOD OF BINDING MATERIAL TO THE Beta-AMYLOID PEPTIDE |
| 02/20/2002 | CN1336957A BASB006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 02/20/2002 | CN1336935A Compositions and methods for WT1 specific immunotherapy |
| 02/20/2002 | CN1336236A Caries resisting immune globulin prepn and its making process |
| 02/19/2002 | US6348586 Nucleotide sequence of herpes virus; diagnosis; vaccines; viricides; antisense agents; triplex oligonucleotides; |
| 02/19/2002 | US6348582 Prokaryotic polynucleotides polypeptides and their uses |
| 02/19/2002 | US6348579 FtsL |
| 02/19/2002 | US6348578 Apt |
| 02/19/2002 | US6348574 An antibody; diagnosis and therapy for tumors, strokes, vasoconstriction, bronchial asthma, and atherosclerosis |
| 02/19/2002 | US6348450 Noninvasive genetic immunization, expression products therefrom and uses thereof |
| 02/19/2002 | US6348449 Methods of inducing mucosal immunity |
| 02/19/2002 | US6348351 Tie receptor tyrosine kinase ligand homologues |
| 02/19/2002 | US6348342 Compounds |
| 02/19/2002 | US6348340 Compounds |
| 02/19/2002 | US6348332 DNA molecule encoding gonorrhoeal hybrid PIA/PIB protein |
| 02/19/2002 | US6348207 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and form orally deliverable supramolecular complex, orally administering complex to subject |
| 02/19/2002 | US6348198 Isolated and purified from a bacterial pathogen selected from neisseria meningitidis, neisseria gonorrhoeae, moraxella catarrhalis, moraxella bovis and moraxella lacunata; immunogenic; |
| 02/19/2002 | US6348197 In ovo vaccination against Newcastle Disease |
| 02/19/2002 | US6348196 Feline polynucleotide vaccine formula |
| 02/19/2002 | US6348194 Tumor specific internalizing antigens and methods for targeting therapeutic agents |
| 02/19/2002 | US6348191 Production and use of IL-6 |
| 02/19/2002 | CA2074730C Immobilized polyethylene oxide star molecules for bioapplications |
| 02/19/2002 | CA2039387C Heat-treated igm antibody preparations |
| 02/19/2002 | CA2023246C Mutants of human interleukin-3 |
| 02/14/2002 | WO2002012899A2 Peptides presented by cells |
| 02/14/2002 | WO2002012538A2 Nucleic acids and pathogenic e.coli proteins, and their uses |
| 02/14/2002 | WO2002012535A1 Use of anti-ceacam antibodies for stimulating b cells in the production of monoclonal antibodies or in immunotherapy |
| 02/14/2002 | WO2002012503A1 Production in pichia pastoris yeast and system for purifying the recombinant allergen of olea europaea ole e 1 for utilization in the diagnosis and treatment of allergies |
| 02/14/2002 | WO2002012502A2 Anti-tnf antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012501A2 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012500A2 Anti-il-12 antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012467A2 Drug metabolizing enzymes |
| 02/14/2002 | WO2002012461A2 Regulation of human membrane-type serine protease |
| 02/14/2002 | WO2002012456A2 Ampk-related serine/threonine kinase, designated snark |
| 02/14/2002 | WO2002012454A1 Virus-like micrograins and process for producing the same |
| 02/14/2002 | WO2002012447A2 Isolation and use of solid tumor stem cells |
| 02/14/2002 | WO2002012347A1 Immunotherapy for chronic myelocytic leukemia |
| 02/14/2002 | WO2002012341A2 Her-2/neu fusion proteins |
| 02/14/2002 | WO2002012331A2 Compositions and methods for the therapy and diagnosis of pancreatic cancer |
| 02/14/2002 | WO2002012325A2 Suppressor gene |
| 02/14/2002 | WO2002012307A1 Urocortin proteins and uses thereof |
| 02/14/2002 | WO2002012294A2 Group b streptococcus polypeptides nucleic acids and therapeutic compositions and vaccines thereof |
| 02/14/2002 | WO2002012292A2 Method of polypeptide renaturation |
| 02/14/2002 | WO2002012289A2 Stabilization of immunogens derived from paramyxoviruses |
| 02/14/2002 | WO2002012288A2 Vaccination against host cell-associated herpesviruses |
| 02/14/2002 | WO2002012287A1 Purification of hbv antigens for use in vaccines |
| 02/14/2002 | WO2002012286A2 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | WO2002012281A2 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen |